Introducing the Carmine Therapeutics Team

XQ Lin

Founding CEO

XQ is the Founder and Managing Partner of Esco Ventures, the corporate venture and incubation arm of Esco Group.

Hon-Ren Huang, Ph.D.

Senior Director of Biology

Dr. Huang received his Ph.D. from the University of Texas Southwestern Medical Center. He completed his post-doctoral training in the laboratory of Prof. Tom Maniatis at Harvard University.

Mark A. Kay MD, PhD

Scientific Advisor

Mark Kay is an acknowledged leader in the field of gene therapy and is a leading researcher in both viral and non-viral gene transfer vector systems.

Ronne Yeo, Ph.D.

Vice President, Discovery

Ronne obtained his Ph.D. in Biological Sciences from the National University of Singapore.

Elan Ezickson

Board Member

Elan Ezickson joined the board in 2019. He brings his extensive strategic, biopharmaceutical, operational, and capital formation expertise to Carmine Therapeutics.

Tenzin Gocha, Ph.D.

Director, Scientific & Business Operations

Tenzin obtained his Ph.D. in Molecular Pharmacology from New York University Medical Center.

Jianzhu Chen, Ph.D.

Scientific Advisor

Jianzhu Chen is a Professor of Biology at the Koch Institute for Integrative Cancer Research and at the Massachusetts Institute of Technology (MIT) Department of Biology.